Showing 1,601–1,650 of 20,598 genes
| # | Gene | Name | Chr | Tags | PubMed | PubMed Papers |
|---|---|---|---|---|---|---|
| 1601 | HADHB | hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta | 2 | Hub GeneOMIM Disease Gene | 243 | 243 |
| 1602 | HSD17B10 | hydroxysteroid 17-beta dehydrogenase 10 | X | OMIM Disease GeneExperimental GO Evidence | 243 | 243 |
| 1603 | MAPK7 | mitogen-activated protein kinase 7 | 17 | KinaseTrending | 243 | 243 |
| 1604 | MYO1C | myosin IC | 17 | TrendingExperimental GO Evidence | 243 | 243 |
| 1605 | PGAM5 | PGAM family member 5, mitochondrial serine/threonine protein phosphatase | 12 | TrendingExperimental GO Evidence | 243 | 243 |
| 1606 | PRKCQ | protein kinase C theta | 10 | KinaseFDA Approved Target | 243 | 243 |
| 1607 | RPL18A | ribosomal protein L18a | 19 | Highly ConstrainedHub Gene | 243 | 243 |
| 1608 | STK4 | serine/threonine kinase 4 | 20 | ApoptosisKinase | 243 | 243 |
| 1609 | ABCC4 | ATP binding cassette subfamily C member 4 (PEL blood group) | 13 | TransporterTrending | 242 | 242 |
| 1610 | ADIPOR1 | adiponectin receptor 1 | 1 | ReceptorTrending | 242 | 242 |
| 1611 | ARMS2 | age-related maculopathy susceptibility 2 | 10 | OMIM Disease GeneExperimental GO Evidence | 242 | 242 |
| 1612 | CCL4 | C-C motif chemokine ligand 4 | 17 | Hub GeneTrending | 242 | 242 |
| 1613 | CD80 | CD80 molecule | 3 | Hub GeneReceptor | 242 | 242 |
| 1614 | CXCR1 | C-X-C motif chemokine receptor 1 | 2 | Hub GeneReceptor | 242 | 242 |
| 1615 | DEFB1 | defensin beta 1 | 8 | Experimental GO EvidenceSwiss-Prot Reviewed | 242 | 242 |
| 1616 | PFKP | phosphofructokinase, platelet | 10 | KinaseTrending | 242 | 242 |
| 1617 | PLA2G2A | phospholipase A2 group IIA | 1 | Clinical TrialsTrending | 242 | 242 |
| 1618 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 4 | Highly ConstrainedHub Gene | 242 | 242 |
| 1619 | SORT1 | sortilin 1 | 1 | ReceptorTransporter | 242 | 242 |
| 1620 | SRSF6 | serine and arginine rich splicing factor 6 | 20 | Hub GeneTrending | 242 | 242 |
| 1621 | STAT2 | signal transducer and activator of transcription 2 | 12 | Hub GeneTranscription Factor | 242 | 242 |
| 1622 | TNFSF12 | TNF superfamily member 12 | 17 | Clinical TrialsTrending | 242 | 242 |
| 1623 | WEE1 | WEE1 G2 checkpoint kinase | 11 | KinaseClinical Trials | 242 | 242 |
| 1624 | AKR1B1 | aldo-keto reductase family 1 member B | 7 | FDA Approved TargetTrending | 241 | 241 |
| 1625 | CD276 | CD276 molecule | 15 | Clinical TrialsTrending | 241 | 241 |
| 1626 | CYP2C8 | cytochrome P450 family 2 subfamily C member 8 | 10 | Hub GeneExperimental GO Evidence | 241 | 241 |
| 1627 | PA2G4 | proliferation-associated 2G4 | 12 | Highly ConstrainedHub Gene | 241 | 241 |
| 1628 | PROCR | protein C receptor | 20 | ReceptorTrending | 241 | 241 |
| 1629 | PSMD14 | proteasome 26S subunit, non-ATPase 14 | 2 | DNA RepairHomologous Recombination | 241 | 241 |
| 1630 | RARS1 | arginyl-tRNA synthetase 1 | 5 | Hub GeneOMIM Disease Gene | 241 | 241 |
| 1631 | SRRM2 | serine/arginine repetitive matrix 2 | 16 | Highly ConstrainedHub Gene | 241 | 241 |
| 1632 | TAC1 | tachykinin precursor 1 | 7 | Hub GeneTrending | 241 | 241 |
| 1633 | AHCY | adenosylhomocysteinase | 20 | OMIM Disease GeneTrending | 240 | 240 |
| 1634 | ANG | angiogenin | 14 | OMIM Disease GeneExperimental GO Evidence | 240 | 240 |
| 1635 | MEF2C | myocyte enhancer factor 2C | 5 | Highly ConstrainedTranscription Factor | 240 | 240 |
| 1636 | NOP58 | NOP58 ribonucleoprotein | 2 | Hub GeneTrending | 240 | 240 |
| 1637 | SPAST | spastin | 2 | OMIM Disease GeneTrending | 240 | 240 |
| 1638 | TRAF1 | TNF receptor associated factor 1 | 9 | Experimental GO EvidenceSwiss-Prot Reviewed | 240 | 240 |
| 1639 | TRPA1 | transient receptor potential cation channel subfamily A member 1 | 8 | Ion ChannelTransporter | 240 | 240 |
| 1640 | WFDC2 | WAP four-disulfide core domain 2 | 20 | OMIM Disease GeneTrending | 240 | 240 |
| 1641 | WNT3A | Wnt family member 3A | 1 | Hub GeneExperimental GO Evidence | 240 | 240 |
| 1642 | BBC3 | BCL2 binding component 3 | 19 | ApoptosisTrending | 239 | 239 |
| 1643 | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | 20 | Highly ConstrainedFDA Approved Target | 239 | 239 |
| 1644 | ELK1 | ETS transcription factor ELK1 | X | Transcription FactorTrending | 239 | 239 |
| 1645 | F11 | coagulation factor XI | 4 | ProteaseFDA Approved Target | 239 | 239 |
| 1646 | IFI16 | interferon gamma inducible protein 16 | 1 | Transcription FactorTrending | 239 | 239 |
| 1647 | P2RY12 | purinergic receptor P2Y12 | 3 | ReceptorFDA Approved Target | 239 | 239 |
| 1648 | SERPINA3 | serpin family A member 3 | 14 | TrendingExperimental GO Evidence | 239 | 239 |
| 1649 | SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 7 | TrendingExperimental GO Evidence | 239 | 239 |
| 1650 | UBTF | upstream binding transcription factor | 17 | Highly ConstrainedTranscription Factor | 239 | 239 |